The Washington Post: Pfizer-BioNTech vaccine neutralizes Brazil variant in lab study as experts warn of rapid spread
The Brazilian variant may lead to reinfection and is more contagious than the original Wuhan strain. There have been at least 15 cases of the Brazil variant in the United States, with a large possibility that many cases have gone unidentified. Recent studies have shown that the Pfizer-BioNTech mRNA vaccine is effective against the Brazil coronavirus variant. Therefore, despite the emerging variants, the vaccines developed within the past year can still help reduce the spread of COVID-19 for the time being. To read the full article, click here. To learn more about vaccines, click here.